Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug
ActiveUID / VAT
CHE-192.967.620 MWST
Commercial Register Number
CH-170-9002314-7
Seat
Zug
Purpose
Zweck der Zweigniederlassung: Herstellung und Vertrieb von pharmazeutischen Produkten.
Management
AI-generated contentJoin Our Beta Program
We are actively developing the platform. Sign up for beta access to get exclusive early access to new features.
Publications
10/14/2025
03/28/2025
02/19/2025
02/08/2024
12/05/2023
07/18/2023
Frequently Asked Questions
What is the legal status of Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug?
Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug is Active in the Swiss Commercial Register.
What is the UID (VAT) number of Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug?
The UID (VAT) number of Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug is CHE-192.967.620.
Where is Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug located?
Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug is located in Zug with its registered address at Grafenaustrasse 5, 6300 Zug.
What is the legal form of Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug?
Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug is registered as a Foreign branch (FB) in Switzerland.
What is the purpose of Kiniksa Pharmaceuticals (UK) Ltd., London (UK), Zweigniederlassung Zug?
Zweck der Zweigniederlassung: Herstellung und Vertrieb von pharmazeutischen Produkten.